p(1),p(5)-di(adenosine-5'-)pentaphosphate has been researched along with boranes in 1 studies
Studies (p(1),p(5)-di(adenosine-5'-)pentaphosphate) | Trials (p(1),p(5)-di(adenosine-5'-)pentaphosphate) | Recent Studies (post-2010) (p(1),p(5)-di(adenosine-5'-)pentaphosphate) | Studies (boranes) | Trials (boranes) | Recent Studies (post-2010) (boranes) |
---|---|---|---|---|---|
215 | 2 | 26 | 1,481 | 5 | 696 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bigonnesse, F; Eliahu, S; Fischer, B; Haas, M; Lecka, J; Lévesque, SA; Pelletier, J; Reiser, G; Sévigny, J | 1 |
1 other study(ies) available for p(1),p(5)-di(adenosine-5'-)pentaphosphate and boranes
Article | Year |
---|---|
Diadenosine 5',5''-(boranated)polyphosphonate analogues as selective nucleotide pyrophosphatase/phosphodiesterase inhibitors.
Topics: Adenine Nucleotides; Adenosine Triphosphate; Boranes; Calcium; Cell Line; Dinucleoside Phosphates; Drug Screening Assays, Antitumor; Humans; Hydrolysis; Nucleotidases; Phosphoric Diester Hydrolases; Purinergic P2Y Receptor Agonists; Pyrophosphatases; Receptors, Purinergic P2Y; Structure-Activity Relationship; Substrate Specificity; Thymidine Monophosphate | 2010 |